Literature DB >> 15921399

The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients.

Benilde Cosmi, Cristina Legnani, Michela Cini, Giuliana Guazzaloca, Gualtiero Palareti.   

Abstract

We assessed the predictive value of D-dimer (D-d) and residual venous obstruction (RVO), alone or in combination, for recurrent venous thromboembolism (VTE) over a 2-year follow-up in a cohort of 88 cancer patients after oral anticoagulant therapy (OAT) withdrawal following a first episode of proximal deep vein thrombosis of the lower limbs. RVO, determined by compression ultrasonography on the day of OAT suspension (T1), and abnormal D-d (cut-off value: 500 ng/mL), measured at T1 and 30+/-10 days afterwards, are independent risk factors for recurrent VTE in cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921399

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  8 in total

1.  Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study.

Authors:  Bruna M Mazetto; Fernanda L A Orsi; Sandra A F Silveira; Luis F Bittar; Mariane M C Flores-Nascimento; Kiara C S Zapponi; Marina P Colella; Erich V de Paula; Joyce M Annichino-Bizzacchi
Journal:  Clin Appl Thromb Hemost       Date:  2017-04-10       Impact factor: 2.389

Review 2.  New insights into cancer-associated thrombosis.

Authors:  Tarek Sousou; Alok A Khorana
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03       Impact factor: 8.311

3.  Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.

Authors:  David A Manly; Jianguo Wang; Sam L Glover; Raj Kasthuri; Howard A Liebman; Nigel S Key; Nigel Mackman
Journal:  Thromb Res       Date:  2009-10-24       Impact factor: 3.944

4.  Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.

Authors:  Marc A Rodger; Susan R Kahn; Philip S Wells; David A Anderson; Isabelle Chagnon; Grégoire Le Gal; Susan Solymoss; Mark Crowther; Arnaud Perrier; Richard White; Linda Vickars; Tim Ramsay; Marisol T Betancourt; Michael J Kovacs
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

Review 5.  Recurrent venous thromboembolism: what is the risk and how to prevent it.

Authors:  Gualtiero Palareti
Journal:  Scientifica (Cairo)       Date:  2012-09-17

6.  A systematic review of the utility of residual vein obstruction studies in primary and secondary venous thrombosis.

Authors:  Murali Janakiram; Matthew Sullivan; Marina Shcherba; Shuang Guo; Henny H Billett
Journal:  Thrombosis       Date:  2013-11-19

Review 7.  Effectiveness of d-dimer as a screening test for venous thromboembolism: an update.

Authors:  Swaroopa Pulivarthi; Murali Krishna Gurram
Journal:  N Am J Med Sci       Date:  2014-10

8.  Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?

Authors:  Otto Moodley; Hadi Goubran
Journal:  Thromb J       Date:  2015-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.